Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations

• Autor(a) principal: Attiq, Ali
• Data de Publicação: 2018
• Outros Autores: Ashraf, Muhammad, Jalil, Juriyati, Javeed, Aqeel, Anjum, Aftab Ahmad, Ullah, Asad, Umair, Muhammad, Ali, Sarwat
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Journal of Pharmaceutical Sciences
• Texto Completo: https://www.revistas.usp.br/bjps/article/view/146838
• topic: Carvedilol; Celecoxib; Mutagenicity; Genotoxicity; Cytotoxicity.

It is understood that drugs regardless of their order of administration can exhibit drug interactions. Established on the fact that treatment of hypertension may last for decades and prolong usage of multiple drug regimen may induce substantial pathophysiological changes. Hence, This study was designed to evaluate the possible synergistic toxic effects of anti-hypertensive (carvedilol), and anti-inflammatory drug (celecoxib) alone and in combinations. Well-established MTT assay, Single Cell Gel Electrophoresis (SCGE) and Ames assay were employed to evaluate the toxicity at cellular level. Results from MTT assay on Vero cell line revealed that drug combinations have more pronounced anti-proliferative activity with combine IC50 value of 13.7:47.8 µg/mL. Likewise, exposure of peripheral blood mononuclear cells with drug combinations revealed significant (P